欢迎来到CSNpharm!产品仅用于科研!

400-920-2911 sales@csnpharm.cn

0

LTR

LTR

货号 产品名 CAS号 信息
CSN12622 Cyclopentyl (3-(2-methoxy-4-((o-tolylsulfonyl)carbamoyl)benzyl)-1-methyl-1H-indol-5-yl)carbamate 107753-78-6 Zafirlukast is the first-approved LTR antagonist with anti-asthmatic and potential capsular contracture-preventing activities.
CSN20247 REV 5901 101910-24-1 Rev-5901 is an antagonist of cysteinyl-leukotriene receptors with a Ki value of 0.7 µM for guinea pig lung membranes. It is also an inhibitor of rat neutrophil 5-LO with an IC50 value of 0.12 µM.
CSN12540 Pranlukast hemihydrate 150821-03-7 Pranlukast is an orally administered, selective, cysteinyl leukotriene receptor-1 antagonist, pranlukast, a widely used leukotriene C4, D4, and E4 antagonist, together with antibiotics could inhibit the progression to SOM.
CSN11761 Pranlukast 103177-37-3 Pranlukast is a selective CysLt1 leukotriene receptor antagonist.
CSN11455 Montelukast Sodium   151767-02-1 Montelukast Sodium is a potent, selective and competitive LTR1 antagonist with IC50 value < 5 nM, possesssing anti-inflammatory and bronchodilating activities.
CSN13506 MK-571 sodium 115103-85-0 MK-571 Sodium is a competitive, potent and selective LTD4 antagonist with Ki values of 0.22 nM.
CSN28763 Etalocib   161172-51-6 LY293111 is a potent LTB4 receptor antagonist with IC50 values of 17.6nM and 6.3nM for inhibition of the specific binding of radiolabeled-LTB4 to isolated human neutrophils and the LTB4-induced chemotaxis of human neutrophils, respectively.
CSN17112 LY255283 117690-79-6 LY255283 is selective, competitive antagonist of BLT2 receptors (IC50 values are ~ 1 and > 10 μM at human recombinant BLT2 and BLT1 receptors respectively), and inhibits LTB4-induced contraction of lung parenchyma (pA2 = 7.2), and reduces LTB4-mediated airway obstruction in guinea pigs following i.v. and oral administration.
CSN22022 LY210073 148291-65-0 LY210073 is a Leukotriene B4 (LTB4) receptor antagonist with IC50 of 6.2 nM.
CSN28403 Leukotriene B4 71160-24-2 Leukotriene B4 is a dihydroxy fatty acid derived from arachidonic acid. It promotes a number of leukocyte functions including aggregation, stimulation of ion fluxes, enhancement of lysosomal enzyme release, superoxide anion production, chemotaxis, and chemokinesis.
CSN22433 Iralukast 151581-24-7 Iralukast is a cysteinyl-leukotriene antagonist (CysLT) with a pKi of 7.8 for CysLT1.
CSN22183 DW-1350 491577-61-8 DW-1350 is a LTB4 receptor antagonist.
CSN17084 5,5'-((2-Hydroxypropane-1,3-diyl)bis(oxy))bis(4-oxo-4H-chromene-2-carboxylic acid) 16110-51-3 Cromoglicic acid is used to treat the symptoms of asthma.
CSN21230 CP-96486 139401-45-9 CP-96486 is a potent and orally active leukotriene D4 (LTD4)/platelet activating factor (PAF) receptor antagonist with Kis of 20 and 24 nM, respectively.
CSN21974 Bunaprolast 99107-52-5 Bunaprolast is a potent inhibitor of LTB4 production in human whole blood and also exhibits significant inhibition of lipoxygenase and TXB2 release.
CSN66589 Ablukast 96566-25-5
<< PREV 1 NEXT >>
联系
我们